• #564814
  • 10
  • Novo Nordisk Pharmaceutical #00169368512

NovoLog® Mix 70/30 Insulin Aspart Protamine / Insulin Aspart 70 U - 30 U / mL Subcutaneous Injection Vial 10 mL

NOVOLOG, VL 70/30U/ML 10ML

Features
  • NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia
  • NovoLog Mix 70/30 is a blood glucoselowering agent with a rapid onset and an intermediate duration of action
  • NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #564814
Manufacturer #00169368512
BrandNovoLog® Mix 70/30
ManufacturerNovo Nordisk Pharmaceutical
Country of OriginUnknown
Alternate Manufacturer Number1145671
ApplicationInsulin
Container TypeVial
Dosage FormInjection
Generic Drug Code19057
Generic Drug NameInsulin Aspart Protamine / Insulin Aspart
NDC Number00169-3685-12
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Storage RequirementsRequires Refrigeration
Strength70 U - 30 U / mL
TypeSubcutaneous
UNSPSC Code51183603
Volume10 mL
Features
  • NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia
  • NovoLog Mix 70/30 is a blood glucoselowering agent with a rapid onset and an intermediate duration of action
  • NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart
  • Presentation contains 100 Units of insulin aspart per mL (U-100)
More Information